Next |
home / stock / teva / teva message board
Subject | By | Source | When |
---|---|---|---|
MomentumIts trading | JLS | investorshub | 05/08/2023 9:55:40 PM |
$TEVA The trading | Zilla | investorshub | 05/08/2023 8:56:28 PM |
and the shorts continue | Tigerbalsam | investorshub | 05/08/2023 3:10:48 AM |
Time for a bounce? | JLS | investorshub | 05/06/2023 5:42:43 PM |
$TEVA good read | WovenO2 | investorshub | 05/06/2023 3:13:04 PM |
$TEVA short data if anyone is interested | altruism | investorshub | 05/06/2023 1:20:35 PM |
Price gaining | JLS | investorshub | 05/05/2023 2:56:58 PM |
MomentumIts trading last trade up | Zilla | investorshub | 05/04/2023 10:16:26 PM |
Found an interesting article | WovenO2 | investorshub | 05/04/2023 1:28:41 PM |
Price now | ClayTrader | investorshub | 05/03/2023 1:57:50 PM |
$TEVA must see | Tigerbalsam | investorshub | 05/02/2023 10:00:18 PM |
short data if anyone is interested | J Pow Wannabe | investorshub | 04/30/2023 7:13:57 AM |
Price now last up | Zilla | investorshub | 04/28/2023 6:02:19 PM |
$TEVA The now last trade up | WovenO2 | investorshub | 04/28/2023 5:51:58 AM |
$TEVA Price trading | FUNMAN | investorshub | 04/27/2023 8:39:37 AM |
$TEVA short squeeze article | weedtrader420 | investorshub | 04/24/2023 11:45:07 PM |
$TEVA Time for a bounce? | JLS | investorshub | 04/24/2023 5:12:58 AM |
$TEVA MomentumIts gaining up | WovenO2 | investorshub | 04/24/2023 2:24:48 AM |
$TEVA short squeeze article | Zilla | investorshub | 04/22/2023 8:03:09 PM |
Have a look at this | Melia10 | investorshub | 04/19/2023 9:05:10 PM |
News, Short Squeeze, Breakout and More Instantly...
Teva Pharmaceutical Industries Limited American Depositary Shares Company Name:
TEVA Stock Symbol:
NYSE Market:
Teva Pharmaceutical Industries Limited American Depositary Shares Website:
SPACE pediatric Phase 3 study met its primary end point for efficacy with a significantly greater reduction in Monthly Migraine Days compared to placebo Efficacy is consistent with AJOVY (fremanezumab) pivotal Phase 3 and Real-World Evidence studies in adults with no new emerg...
2024-07-10 08:00:08 ET Ashwani Verma from UBS issued a price target of $24.00 for TEVA on 2024-07-10 07:20:00. The adjusted price target was set to $24.00. At the time of the announcement, TEVA was trading at $15.81. The overall price target consensus is at $15.00 with h...
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2024 financial results on Wednesday, July 31, 2024, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8...